Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 open-label mass balance study of 14C-JNJ-63623872 in healthy men
NL-OMON42724Phase 1Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pimodivir in Influenza A infection, sponsored by Janssen Pharmaceutical. Primary endpoint: Absorption, metabolism, and excretion of JNJ-63623872. Started May 2015; status: active, not recruiting.
02
Drugs
pimodivir
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on NL-OMON42724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42724.